Psychiatry and Neurology, Neurology · Kansas City, MO
NPI
1962817130
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4400 Broadway St, Ste 520
Kansas City, MO, 64111
Phone (816) 960-7600
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
27,008 services
Medicare patients, 2024
658
Average age 75
Drug cost, 2024
$1.4M
8,389 prescriptions
Company payments, 2025
$376
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karl N Knights was code J0585 (injection, onabotulinumtoxina, 1 unit), 25,500 times for 48 patients. In total Karl N Knights billed 27,008 services in 25 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 25,500 | 48 | $4.98 | $127K |
| 99215 Office E&M - Established | Office | 297 | 267 | $121.02 | $36K |
| 95984 Electrical Nerve Conductivity | Office | 225 | 40 | $28.77 | $6,474 |
| 99214 Office E&M - Established | Office | 175 | 168 | $87.60 | $15K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 135 | 79 | $23.58 | $3,183 |
| 99213 Office E&M - Established | Office | 115 | 111 | $59.62 | $6,856 |
| 95874 Musculoskeletal | Office | 103 | 42 | $53.66 | $5,527 |
| 95983 Electrical Nerve Conductivity | Office | 77 | 41 | $32.78 | $2,524 |
| 99205 Office E&M - New | Office | 75 | 75 | $144.23 | $11K |
| 64616 Musculoskeletal | Office | 58 | 25 | $142.43 | $8,261 |
| 64612 Musculoskeletal | Office | 40 | 16 | $113.30 | $4,532 |
| 64642 Musculoskeletal | Office | 30 | 12 | $105.28 | $3,158 |
| 99204 Office E&M - New | Office | 14 | 14 | $100.48 | $1,407 |
| 99212 Office E&M - Established | Office | 13 | 13 | $39.78 | $517 |
By year: 2022 $170K for 13,768 services; 2023 $170K for 16,018 services; 2024 $236K for 27,008 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karl N Knights prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,659 prescriptions and refills. In total Karl N Knights wrote 8,389 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,659 | 3,738 | 449 | $61K |
| Donepezil Hcl Generic | 664 | 1,372 | 179 | $6,154 |
| Primidone Generic | 480 | 1,026 | 123 | $17K |
| Amantadine Amantadine Hcl | 471 | 812 | 128 | $19K |
| Gabapentin Generic | 442 | 862 | 125 | $11K |
| Clonazepam Generic | 424 | 545 | 79 | $3,590 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 345 | 818 | 95 | $14K |
| Zonisamide Generic | 303 | 540 | 84 | $5,824 |
| Baclofen Generic | 232 | 404 | 69 | $5,453 |
| Memantine Hcl Generic | 195 | 402 | 44 | $4,034 |
| Levetiracetam Generic | 194 | 322 | 47 | $4,992 |
| Propranolol Hcl Er Propranolol Hcl | 193 | 414 | 47 | $7,611 |
| Mirtazapine Generic | 179 | 326 | 50 | $2,654 |
| Rivastigmine Rivastigmine Tartrate | 178 | 292 | 46 | $11K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 161 | 337 | 44 | $3,999 |
Brand drugs: 381 claims; generic drugs: 8,008 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl N Knights $376 ($376 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $176.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.